Literature DB >> 24519704

[Vaccinations for international travelers].

N Berens-Riha1, M Alberer, T Löscher.   

Abstract

Vaccinations are a prominent part of health preparations before international travel. They can avoid or significantly reduce the risk of numerous infectious diseases. Until recently, vaccination against yellow fever was the only obligatory vaccination. However, according to updated international health regulations, other vaccinations and prophylactic measures may be required at entry from certain countries. For all routine vaccinations as recommended in Germany, necessary revaccination and catch-up of missed vaccinations should be administered before travel. At most destinations the risk of infection is higher than in Germany. Hepatitis A vaccine is generally recommended for travelers to areas of increased risk, polio vaccine for all destinations where eradication is not yet confirmed (Asia and Africa). The indications for other travel vaccines must take into consideration travel destination and itinerary, type and duration of travel, individual risk of exposure as well as the epidemiology of the disease to be prevented. Several vaccines of potential interest for travel medicine, e.g., new vaccines against malaria and dengue fever, are under development.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24519704     DOI: 10.1007/s00108-013-3365-x

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  13 in total

1.  Meningococcal disease: the organism, clinical presentation, and worldwide epidemiology.

Authors:  Jaffar A Al-Tawfiq; Thomas A Clark; Ziad A Memish
Journal:  J Travel Med       Date:  2010 Sep-Oct       Impact factor: 8.490

Review 2.  Review of dengue virus and the development of a vaccine.

Authors:  Sarah Murrell; Suh-Chin Wu; Michael Butler
Journal:  Biotechnol Adv       Date:  2010-12-10       Impact factor: 14.227

Review 3.  Vaccines for preventing typhoid fever.

Authors:  A Fraser; E Goldberg; C J Acosta; M Paul; L Leibovici
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

4.  Japanese encephalitis in travelers from non-endemic countries, 1973-2008.

Authors:  Susan L Hills; Anne C Griggs; Marc Fischer
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

5.  Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events.

Authors:  Alena Y Khromava; Rachel Barwick Eidex; Leisa H Weld; Katrin S Kohl; Robert D Bradshaw; Robert T Chen; Martin S Cetron
Journal:  Vaccine       Date:  2005-05-09       Impact factor: 3.641

6.  Two laboratory-confirmed cases of Japanese encephalitis imported to Germany by travelers returning from Southeast Asia.

Authors:  Dennis Tappe; Andrea Nemecek; Frauke Zipp; Petra Emmerich; Martin Gabriel; Stephan Günther; Gerhard Dobler; Jonas Schmidt-Chanasit; August Stich
Journal:  J Clin Virol       Date:  2012-03-31       Impact factor: 3.168

7.  Animal-associated injuries and related diseases among returned travellers: a review of the GeoSentinel Surveillance Network.

Authors:  Philippe Gautret; Eli Schwartz; Marc Shaw; Georges Soula; Pierre Gazin; Jean Delmont; Philippe Parola; Marie José Soavi; Elizabeth Matchett; Graham Brown; Joseph Torresi
Journal:  Vaccine       Date:  2007-01-03       Impact factor: 3.641

Review 8.  Human rabies: neuropathogenesis, diagnosis, and management.

Authors:  Thiravat Hemachudha; Gabriella Ugolini; Supaporn Wacharapluesadee; Witaya Sungkarat; Shanop Shuangshoti; Jiraporn Laothamatas
Journal:  Lancet Neurol       Date:  2013-05       Impact factor: 44.182

9.  Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.

Authors:  Philip Bejon; John Lusingu; Ally Olotu; Amanda Leach; Marc Lievens; Johan Vekemans; Salum Mshamu; Trudie Lang; Jayne Gould; Marie-Claude Dubois; Marie-Ange Demoitié; Jean-Francois Stallaert; Preeti Vansadia; Terrell Carter; Patricia Njuguna; Ken O Awuondo; Anangisye Malabeja; Omar Abdul; Samwel Gesase; Neema Mturi; Chris J Drakeley; Barbara Savarese; Tonya Villafana; W Ripley Ballou; Joe Cohen; Eleanor M Riley; Martha M Lemnge; Kevin Marsh; Lorenz von Seidlein
Journal:  N Engl J Med       Date:  2008-12-08       Impact factor: 91.245

10.  Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.

Authors:  Sari H Pakkanen; Jussi M Kantele; Anu Kantele
Journal:  Vaccine       Date:  2012-08-02       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.